{"id":38211,"date":"2020-09-06T04:25:02","date_gmt":"2020-09-06T04:25:02","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=38211"},"modified":"2020-09-06T04:25:02","modified_gmt":"2020-09-06T04:25:02","slug":"hiv-1-and-hiv-2","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/hiv-1-and-hiv-2\/","title":{"rendered":"HIV- 1  and HIV-2"},"content":{"rendered":"<p>Two viruses identified (so far) which cause acquired immune deficiency syndrome (AIDS). HIV-1 and HIV-2 show a preferential tropism (affinity) toward the helper T cells, although other immune system (and nervous system) cells are also infected. The GP120 envelope (surface) protein of HIV-1 and HIV-2 directly interacts (binds) with the CD4 proteins (receptors) on the surface of helper T cells, enabling the viruses to bind (attach to) and infect the helper T cells. In order to successfully enter and infect cells, the HIV must also bind with CKR-5 proteins (receptors) located on the surface of cells of most humans. In 1996, Nathaniel Landau and Richard Koup discovered that approximately one percent of humans carry a gene for a version of CKR-5 receptor that resists entry to cells by HIV. As of 1996, a total of nine separate strains (serotypes) of Human Immunodeficiency Virus were known; identified by the letters A, B, C, D, E, F, G, H, I.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Two viruses identified (so far) which cause acquired immune deficiency syndrome (AIDS). HIV-1 and HIV-2 show a preferential tropism (affinity) toward the helper T cells, although other immune system (and nervous system) cells are also infected. The GP120 envelope (surface) protein of HIV-1 and HIV-2 directly interacts (binds) with the CD4 proteins (receptors) on the [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[],"class_list":["post-38211","post","type-post","status-publish","format-standard","hentry","category-h"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>HIV- 1 and HIV-2 - Definition of HIV- 1 and HIV-2<\/title>\n<meta name=\"description\" content=\"Two viruses identified (so far) which cause acquired immune deficiency syndrome (AIDS). HIV-1 and HIV-2 show a preferential tropism (affinity) toward the helper T cells, although other immune system (and nervous system) cells are also infected. The GP120 envelope (surface) protein of HIV-1 and HIV-2 directly interacts (binds) with the CD4 proteins (receptors) on the surface of helper T cells, enabling the viruses to bind (attach to) and infect the helper T cells. In order to successfully enter and infect cells, the HIV must also bind with CKR-5 proteins (receptors) located on the surface of cells of most humans. In 1996, Nathaniel Landau and Richard Koup discovered that approximately one percent of humans carry a gene for a version of CKR-5 receptor that resists entry to cells by HIV. As of 1996, a total of nine separate strains (serotypes) of Human Immunodeficiency Virus were known; identified by the letters A, B, C, D, E, F, G, H, I.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/hiv-1-and-hiv-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HIV- 1 and HIV-2 - Definition of HIV- 1 and HIV-2\" \/>\n<meta property=\"og:description\" content=\"Two viruses identified (so far) which cause acquired immune deficiency syndrome (AIDS). HIV-1 and HIV-2 show a preferential tropism (affinity) toward the helper T cells, although other immune system (and nervous system) cells are also infected. The GP120 envelope (surface) protein of HIV-1 and HIV-2 directly interacts (binds) with the CD4 proteins (receptors) on the surface of helper T cells, enabling the viruses to bind (attach to) and infect the helper T cells. In order to successfully enter and infect cells, the HIV must also bind with CKR-5 proteins (receptors) located on the surface of cells of most humans. In 1996, Nathaniel Landau and Richard Koup discovered that approximately one percent of humans carry a gene for a version of CKR-5 receptor that resists entry to cells by HIV. As of 1996, a total of nine separate strains (serotypes) of Human Immunodeficiency Virus were known; identified by the letters A, B, C, D, E, F, G, H, I.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/hiv-1-and-hiv-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2020-09-06T04:25:02+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/hiv-1-and-hiv-2\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/hiv-1-and-hiv-2\/\",\"name\":\"HIV- 1 and HIV-2 - Definition of HIV- 1 and HIV-2\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2020-09-06T04:25:02+00:00\",\"dateModified\":\"2020-09-06T04:25:02+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"Two viruses identified (so far) which cause acquired immune deficiency syndrome (AIDS). HIV-1 and HIV-2 show a preferential tropism (affinity) toward the helper T cells, although other immune system (and nervous system) cells are also infected. The GP120 envelope (surface) protein of HIV-1 and HIV-2 directly interacts (binds) with the CD4 proteins (receptors) on the surface of helper T cells, enabling the viruses to bind (attach to) and infect the helper T cells. In order to successfully enter and infect cells, the HIV must also bind with CKR-5 proteins (receptors) located on the surface of cells of most humans. In 1996, Nathaniel Landau and Richard Koup discovered that approximately one percent of humans carry a gene for a version of CKR-5 receptor that resists entry to cells by HIV. As of 1996, a total of nine separate strains (serotypes) of Human Immunodeficiency Virus were known; identified by the letters A, B, C, D, E, F, G, H, I.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/hiv-1-and-hiv-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/hiv-1-and-hiv-2\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/hiv-1-and-hiv-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HIV- 1 and HIV-2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HIV- 1 and HIV-2 - Definition of HIV- 1 and HIV-2","description":"Two viruses identified (so far) which cause acquired immune deficiency syndrome (AIDS). HIV-1 and HIV-2 show a preferential tropism (affinity) toward the helper T cells, although other immune system (and nervous system) cells are also infected. The GP120 envelope (surface) protein of HIV-1 and HIV-2 directly interacts (binds) with the CD4 proteins (receptors) on the surface of helper T cells, enabling the viruses to bind (attach to) and infect the helper T cells. In order to successfully enter and infect cells, the HIV must also bind with CKR-5 proteins (receptors) located on the surface of cells of most humans. In 1996, Nathaniel Landau and Richard Koup discovered that approximately one percent of humans carry a gene for a version of CKR-5 receptor that resists entry to cells by HIV. As of 1996, a total of nine separate strains (serotypes) of Human Immunodeficiency Virus were known; identified by the letters A, B, C, D, E, F, G, H, I.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/hiv-1-and-hiv-2\/","og_locale":"en_US","og_type":"article","og_title":"HIV- 1 and HIV-2 - Definition of HIV- 1 and HIV-2","og_description":"Two viruses identified (so far) which cause acquired immune deficiency syndrome (AIDS). HIV-1 and HIV-2 show a preferential tropism (affinity) toward the helper T cells, although other immune system (and nervous system) cells are also infected. The GP120 envelope (surface) protein of HIV-1 and HIV-2 directly interacts (binds) with the CD4 proteins (receptors) on the surface of helper T cells, enabling the viruses to bind (attach to) and infect the helper T cells. In order to successfully enter and infect cells, the HIV must also bind with CKR-5 proteins (receptors) located on the surface of cells of most humans. In 1996, Nathaniel Landau and Richard Koup discovered that approximately one percent of humans carry a gene for a version of CKR-5 receptor that resists entry to cells by HIV. As of 1996, a total of nine separate strains (serotypes) of Human Immunodeficiency Virus were known; identified by the letters A, B, C, D, E, F, G, H, I.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/hiv-1-and-hiv-2\/","og_site_name":"Glossary","article_published_time":"2020-09-06T04:25:02+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/hiv-1-and-hiv-2\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/hiv-1-and-hiv-2\/","name":"HIV- 1 and HIV-2 - Definition of HIV- 1 and HIV-2","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2020-09-06T04:25:02+00:00","dateModified":"2020-09-06T04:25:02+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"Two viruses identified (so far) which cause acquired immune deficiency syndrome (AIDS). HIV-1 and HIV-2 show a preferential tropism (affinity) toward the helper T cells, although other immune system (and nervous system) cells are also infected. The GP120 envelope (surface) protein of HIV-1 and HIV-2 directly interacts (binds) with the CD4 proteins (receptors) on the surface of helper T cells, enabling the viruses to bind (attach to) and infect the helper T cells. In order to successfully enter and infect cells, the HIV must also bind with CKR-5 proteins (receptors) located on the surface of cells of most humans. In 1996, Nathaniel Landau and Richard Koup discovered that approximately one percent of humans carry a gene for a version of CKR-5 receptor that resists entry to cells by HIV. As of 1996, a total of nine separate strains (serotypes) of Human Immunodeficiency Virus were known; identified by the letters A, B, C, D, E, F, G, H, I.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/hiv-1-and-hiv-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/hiv-1-and-hiv-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/hiv-1-and-hiv-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"HIV- 1 and HIV-2"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/38211","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=38211"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/38211\/revisions"}],"predecessor-version":[{"id":38212,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/38211\/revisions\/38212"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=38211"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=38211"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=38211"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}